I dont believe cancer vaccines are in the interest of GSK.
That was a reply I got around 6 - 8 months back when I highlighted PRR to Christopher Francis at GSK, who heads up the Oncology business development unit. Maybe times have changed or that was a throw away line..........
See the attached link and feel free to email him:
www.gsk.com/collaborations/downloads/WWBD-mini-brochure.pdf
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
-0.010(3.85%) |
Mkt cap ! $366.9M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 24.8¢ | $362.9K | 1.448M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 42000 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 271046 | 5 |
View Market Depth
| Last trade - 16.10pm 16/09/2025 (20 minute delay) ? |
| IMM (ASX) Chart |